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ABSTRACT: To date, many osteochondral regenerative approaches have utilized varied combinations of biocompatible materials and
cells to engineer cartilage. Even in cell-based approaches, to date, no study has utilized stem cell aggregates alone for regenerating
articular cartilage. Thus, the purpose of this study was to evaluate the performance of a novel stem cell-based aggregate approach in a
fibrin carrier to regenerate osteochondral defects in the Sprague-Dawley rat trochlear groove model. Two different densities of rat bone
marrow mesenchymal stem cell (rBMSC) aggregates were fabricated by the hanging drop technique. At 8 weeks, the cell aggregates
supported the defects and served as a catalyst for neo-cartilage synthesis, and the experimental groups may have been beneficial for
bone and cartilage regeneration compared to the fibrin-only control and sham groups, as evidenced by histological assessment. The cell
density of rBMSC aggregates may thus directly impact chondrogenesis. The usage of cell aggregates with fibrin as a cell-based
technology is a promising and translational new treatment strategy for repair of cartilage defects. ß 2016 Orthopaedic Research
Society. Published by Wiley Periodicals, Inc. J Orthop Res 35:1606–1616, 2017.
Keywords: osteochondral; trochlear groove; rBMSC; aggregates; fibrin

In the United States, articular defects and agingrelated arthritis is a growing concern and there is an
unmet need to develop long-term and substantial
cost-effective treatments for osteoarthritis.1–3 Over
the last couple of decades, numerous strategies have
been developed in an effort to regenerate the osteochondral interface4–10 that employ autologous cell
suspensions of either differentiated chondrocytes or
undifferentiated bone marrow-derived mesenchymal
stem cells (BMSCs).9,11,12 Several review papers discuss various types of cell-based approaches and the
relative advantages they impose compared to other
material-based strategies.13–16 Current techniques
typically engage MSC monolayers or sheets that are
directly implanted into the periosteal space. Cellular
monolayers are not only mechanically unstable, but
also may not adhere to the defect region, thus posing
a serious concern of cellular retention. In the present
study, the fibrin coating of the aggregates was leveraged to secure the cells to the defect region by
providing anchorage and mechanical support. Apart
from superior survival and retention properties, cellular aggregates may recapitulate embryonic events
during skeletal tissue formation, thus providing an
appropriate microenvironment for cellular differentiation. In addition, the current study exploited the
regenerative capacity by placing several aggregates
in close proximity to maximize opportunities for
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co-differentiation. It is commonly known that culturing cells in pellets is preferred for chondrogenesis,
and ultimately it is our hope that aggregate-based
approaches to cell-based cartilage therapies can overcome the long-standing challenge of regenerating true
hyaline cartilage. Despite the success of cell-based
techniques, clinical outcomes are significantly affected
by the formation of fibrocartilage after long-term
implantation, thus requiring multiple surgeries that,
in turn, may give rise to donor site morbidity and
increase the overall cost of healthcare.17,18 To overcome the above listed disadvantages, investigators
have resorted to employing cells in combination with
biocompatible natural materials such as alginate,
agarose, collagen, and silk fibroin, and polymers such
as polylactic-co-glycolic acid, polyglycolic acid, and
polycaprolactone, which under certain fabrication
conditions may possess mechanical properties similar
to the native cartilage.19–22
While there have been several advances for in vivo
approaches for cartilage tissue engineering using cellbased strategies, the number of cell aggregate
approaches are limited.9,23–27 Commonly, aggregates
have been explored for pancreatic islet regeneration,
targeted drug delivery approaches for cancer therapy,
and generally they serve as representative threedimensional cellular model for drug testing.9,28–31 In
our previous study, aggregates and cell suspensions
were explored in vitro and compared for cartilage
tissue engineering applications.32 For the purpose of
translational application, the aggregate group that
demonstrated superior chondrogenesis compared to
the cell suspension group was chosen for further in
vivo studies that are described here. Translating the
aggregate technology to regenerate articular cartilage
is starting to gain interest.31,33–35
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During the last decade, fibrin has been increasingly
used as a gel, by itself or as a combination delivery
system along with cells and other bioactive factors in a
cartilage tissue-engineering context.36–39 The current
model may serve as a basis for evaluating the role of
fibrin with aggregate delivery and fill the gap in the
literature that may help the iteration of aggregatebased approaches.
Looking at material-based approaches in rat models,
a steady number of studies use external chemical
stimuli such as raw materials, growth factors, and other
bioactive molecules in their scaffolds.40–42 Specifically,
TGF-b1 and TGF-b3 are known to promote chondrogenesis, and BMP-2 and BMP-7 are known to promote
osteogenesis.43–45 Cellular aggregates employed in the
current study, however, provide a more translational
approach by exploiting known intercellular communication from cell pellet cultures in chondrogenesis as an
inherent cue to differentiate MSCs toward the cartilage
phenotype.
Small animal models such as rodents are considered
valid as proof of concept and preliminary research
models.46,47 Since this is the first time we are seeking
to employ cell aggregates with fibrin for articular
cartilage regeneration, a critical sized defect of the
trochlear groove was selected as a reasonable defect
area based on established precedent in the
literature.47–49 The current study investigated cartilage regeneration in a critical sized trochlear groove
defect in Sprague-Dawley rats with cell aggregates of
different densities, and compared the performance
with a fibrin-only control group and a sham negative
control group. Regeneration was evaluated at 8 weeks
with gross morphological scoring and histological
staining. The goal of this pilot study was to determine
whether the cell aggregates would facilitate neocartilage formation in the rat trochlear groove as a
foundation for future in vivo studies.

MATERIALS AND METHODS
Cell Harvest and Culture
Rat bone marrow-derived mesenchymal stem cells (rBMSC)
were harvested from the femurs of five young male SpragueDawley rats (7 weeks old, 200–250 g, Charles River) following a University of Kansas approved Institutional Animal
Care and Use Committee (IACUC) protocol (175–08). The
IACUC approved the use of rBMSC cells for use in this
particular study. The cells were isolated according to our
previously reported protocol.40,50 Briefly, isolated cells were
cultured in rBMSC media (aMEM supplemented with 10%
MSC-qualified FBS and 1% Penicillin-Streptomycin [Invitrogen Life Technologies, Carlsbad, CA]), and passaged at 80%
confluence until P4 at standard condition (37˚C and 5% CO2).
All cells from different femurs were pooled together, frozen
at P2 and later expanded to P4, and used for the study.
Cellular Aggregate Preparation
Aggregates for the current study were generated by the
hanging drop technique.51,52 Cellular suspensions (rBMSC)
were prepared at two concentrations, either 10.0  106 or
20.0  106 cells/ml, in rBMSC media. The cellular concentration
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was confirmed using a Cellometer automatic T4 cell viability
counter (Nexcelcom Bioscience, Lawrence, MA). Droplets of cell
suspensions at a controlled volume of 10 ml that had 10,000 or
20,000 cells were pipetted in an array onto the inside surface of
a sterile petri dish lid using a 10 ml pipette (Eppendorf,
Hauppauge, NY), making sure that the droplets were at safe
distance from each other to prevent mixing. The cells were
allowed to aggregate overnight, aided by gravity when the
petri dish was reversed. The sterile petri dish bottom was then
filled with sterile PBS to prevent drying of these droplets. After
24 h, the cell aggregates were carefully collected from the dish
with a 1 ml pipette and collected in Eppendorf tubes for the
study. Aggregates were placed in defects within 3 h of harvest,
as noted below.
Description of Experimental Groups
Four different treatment groups were investigated: (i) Group
A, where the defect was created and filled with 75 rBMSC
aggregates, each with a cell density of 10 million/ml (note:
Density based on volume of initial 10 ml suspension); (ii)
Group B, where the defect was created and filled with 75
rBMSC aggregates each with cell density of 20 million/ml;
(iii) sham surgery, in which a defect was created, but no
implant was placed; and (iv) fibrin group where the defect
was created and only fibrin was used to fill the defects
(Supplemental Fig. S1). For group (i) and (ii), each petri-dish
used to make the hanging drop aggregates had exactly 75
drops and care was taken to harvest all of the aggregates,
thus making sure we had 75 aggregates for each knee.
Surgical Procedure
Surgical procedures were conducted under an approved
IACUC protocol at the University of Kansas (Animal Use
Statement #175-20), utilizing a total of 10 male SpragueDawley rats (200–250 g, Charles River). The IACUC approved
the protocol to be used for this particular study. Following
stable general anesthesia, hair was shaved from the area
around each rat knee. The knee was then disinfected with
three alternate scrubs of Betadine and 70% ethanol, and then
draped so as to expose only the knee area. Care was taken to
use only strict aseptic techniques and sterile instruments; and
the surgeon wore sterile gowns, masks, and head covers. All
surgical tools, including drills and stoppers, were sterilized
prior to surgery. A midline knee incision was made for an
intra-articular lateral parapatellar arthrotomy sufficient
enough to allow exposure of the trochlear groove. The
osteochondral defect was drilled to a depth of 2.0 mm depth
and 2.0 mm diameter using a drill with a stopper attached to
the bit, thereby breaching the osteochondral plate. There was
mild bleeding into the defect site. Defects were then filled
with either the aggregate groups (Group A or B), or fibrin
(Tisseel1, Baxter, Deerfield, IL) (Supplemental Fig. S1). The
aggregates were harvested 3 h before the surgery, as noted in
the “Cellular aggregate preparation” subsection above, and
immersed in rBMSC media until implantation. At the time of
implantation, aggregates were carefully pipetted into the
defect area. Sham defects were created, in which a hole was
drilled, but no implant was placed. Following implantation of
the aggregate groups, 50 ml of fibrin was added on top of the
aggregates to seal the clot with the surrounding tissue.
Although 6 ml was enough to cover the defect, extra fibrin was
added to secure the clot with the surrounding tissue as it
hardened over time. For the fibrin group, 50 ml of fibrin was
added to the defect similar to the procedure followed for group
JOURNAL OF ORTHOPAEDIC RESEARCH AUGUST 2017
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A and B. The sealing time was approximately 2 min. The joint
was then washed with sterile pharmaceutical grade saline
water and the bursa was closed with absorbable suture. The
skin was then closed with polysorb 3.0, a non-absorbable
suture. The procedure was followed on the contralateral knee
with a different group to ensure independence of knees within
groups (Supplemental Fig. S2). After the surgery was completed, the rats were administered carprofen subcutaneously,
and returned to be caged individually.
Post-Surgical Care
The rats were continuously monitored for the first 3 days
and any signs of limping or unease was treated with
carprofen injection administered subcutaneously only once a
day. Three times a week, the rats were monitored for general
mobility, specific mobility of hind legs, response to touch, and
signs of inflammation at the surgical area. No adverse events
were observed and all the rats progressed at a healthy rate
during the entire period of 8 weeks.
Morphological Analysis of the Retrieved Implants
At 8 weeks, the rats were euthanized by controlled exposure
to CO2 that was approved by the IACUC protocol. After the
joint retrieval, the knees were scored blindly by three
independent co-authors. The scoring was carried out for
macroscopic observations based on the presence of repair
tissue, edge integration at the boundaries of newly regenerated tissue and the native cartilage, smoothness of the
repair surface, degree of filling at the cartilage surface, color
of the regenerated cartilage, and the percent of repair tissue
relative to the total area. The scoring criteria were developed
as a modification from the ICRS scoring chart, represented
in Table S2.53 The joints were photographed and processed
for histology.
Histological Preparation and Staining
At 8 weeks, the rat knees were retrieved and immediately
placed in 10% neutral buffered formalin (Fisher Scientific,
Rockville, NJ) for 72 h, changed every 24 h. After fixation,
the joints were rinsed in distilled water and decalcified (Cal
Rite, Richard-Allan Scientific, Kalamazoo, MI) for 2 weeks
and the solution was changed every 3 days. After decalcification, the knees were rinsed briefly and dehydrated in graded
ethanol. For paraffin embedding, the samples were cleared
with xylene, then infiltrated with paraffin, with the infiltrate
being changed every 3 h.
After three infiltrations, the trochlear grooves were
embedded in paraffin tissue cassettes and allowed to cool
down before sectioning. Sagittal sections were taken on a
microtome (Thermo Scientific; Microm HM 355S) using a
tungsten carbide blade with a sample thickness of 7 mm,
placed on coated glass slides (Superfrost coated slides,
Thermo Scientific, NJ) and dried for 24 h at 44˚C. The glass
slides were cleared in xylene and slowly hydrated in series
of ethanol according to a procedure previously reported.4
After incubating the slides in ddH2O for 5 min, the slides
were stained with either Safranin-O/Fast green stain for
glycosaminoglycans (GAGs) or hematoxylin and eosin to
look at overall structure. Slides were briefly dehydrated
and cleared in xylene for mounting. Furthermore, additional slides were processed for immunohistochemistry
(collagen I, II, and aggrecan) discussed in the next section.
All staining reagents were purchased from Sigma–Aldrich
(St Louis, MO).
JOURNAL OF ORTHOPAEDIC RESEARCH AUGUST 2017

Immunohistochemistry
The slides were processed similar to basic histology as
described above up through hydration in distilled water. The
sections were then exposed to 3% hydrogen peroxide in
methanol for 10 min to suppress endogenous peroxidase
activity, and the slides were immediately incubated in
proteinase K (IHCWORLD IW-1101, Woodstock, MD) at
37˚C for 10 min. Sections were blocked with 3% blocking
horse serum (Vector Laboratories S-2012, Burlingame, CA)
for 30 min preceding primary antibody incubation. The
primary antibodies used in the current study were obtained
from Abcam (Cambridge, MA): collagen I (catalog no:
AB24133, dilution 1:200), collagen II (catalog no: AB116142,
dilution 1:200), and aggrecan (catalog no: AB36861, dilution
1:100). Following primary antibody incubation, slides were
exposed to biotinylated secondary antibody (horse anti-rabbit
IgG) and ABC reagent (Vectastain ABC kit PK-6200, Burlingame, CA) for 30 min each. Visualization was accomplished
with ImmPact DAB peroxidase substrate (Vector laboratories
SK-4105, Burlingame, CA) before rinsing with distilled water
and counter-stained with VECTOR hematoxylin QS stain.
Following staining, slides were rinsed in tap water, dehydrated in ethanol, cleared in xylene for mounting (Permount
SP15-500 Fair Lawn, NJ), and viewed under an upright
microscope (Zeiss, Axiomanager 2.0, Thornswood, NY).
Histology Scoring
A simple scoring system (Table S1) was modified from the
previously reported system by O’Driscoll et al.54 to evaluate
the cartilage and bone regeneration of this pilot study.
Three-blinded observers performed all scoring and the assignment of the scores was aided by evaluating structure
using histological and immunohistological images.
Statistical Analyses
Wherever applicable, all data are expressed as mean  standard deviation. Statistical analyses were performed using
one-way ANOVA (Minitab 15, Minitab Incorporated, State
College, PA), followed by a Tukey’s post hoc comparison test
for repeated measurements. The statistical significance
threshold was set at 0.05 for all tests (with p < 0.05).

RESULTS
Gross Morphological Observations
All of the rats continued to exhibit normal movement
and gait in their hind legs during the 8-week period
except three rats (R03, R05, and R07) that had signs
of limping/uneasiness in their walking gait during the
first week alone. Gross signs of inflammation (swelling
or reddening of the joint) or infection were not evident
upon visual inspection of the joint surface at the time
of tissue retrieval. Figure 1 shows representative gross
morphology images of the rat trochlear grooves at
8 weeks. For Group B, the repair tissue was
completely flush to the surface and had a smooth
texture surrounding the defect area with color similar
to the native cartilage, whereas all of the other groups
had an opaque, slightly depressed, or overgrown
surface with either rough or intermediate texture at
8 weeks. Figure 2a represents the mean morphological
score and Figure 2b represents the percent defect area
fill occupied by the regenerated cartilage with respect
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Figure 1. Representative gross morphological
images of all the experimental and control Groups.
They are divided into three categories based on
the relative morphological appearance. The repair
tissue was opaque, completely flush to the surface,
and had smooth texture in Group B implants,
whereas all of the other groups had opaque,
slightly depressed, or overgrown surface, with
either a rough or intermediate texture at 8 weeks.
(Circled region points to the defect area on the
trochlear groove on the retrieved knees). Scale
bar ¼ 2 mm.

to the total defect area was determined macroscopically for each sample at 8 weeks. The percent area
values were between 80% and 95% for Group A and
the sham and Fibrin group. Group B values were
between 95% and 100%. Group B received a statistically significantly higher morphological score (Fig. 2a)
than Group A alone (p < 0.05). Group B did not have a
statistically significantly higher score compared to
sham and fibrin group. The difference in mean morphological score between Group A and fibrin group
and sham group was not statistically significant.

Figure 2. (a) Average morphological score of the rat knees. (b)
Percentage defect repair area coverage evaluating the percentage
of repair tissue filled at the defect site in for all the groups. Three
independent co-authors compiled morphological scores based on
parameters in Table S1. Average scores are represented as
average  standard deviation. The maximum possible score a
healthy cartilage can receive is 10/100 correspondingly. All
groups had a sample size of n ¼ 5. ( ) Indicates statistically
significant difference from Group A.

Histomorphometric Observations
Figure 3 shows representative sections stained with
H&E, Safranin O for GAGs, collagen I, II, and
aggrecan immunostaining, for Group A. Rat #2 (i.e.,
R02) (Fig. 2) had intense Saf-O staining, whereas R04
and
R09
did
not
stain
very
intensely.
Figure 4b represents the morphometric score distribution of Saf-O stained sections of the defect area, and
we observed that 40% of the knees were slightly
stained, 20% were moderately stained, and the
remaining 40% was normally stained. Collagen II
staining was prominent in the defect region for R03
and R04, and aggrecan immunostaining was intense
for R04 and R09 cartilage region. There was no intense
staining of collagen I around the defect area, but
overall there was a mild staining throughout the
subchondral bone region. Sixty percent of Group A
knees received a score of 2 (75–100% of adjacent
cartilage) and the remaining 40% received a score of 3
(100% thickness of the adjacent cartilage) (Fig. 4a).
Additionally, 60% of the Group A knees showed
normal subchondral bone regeneration with smooth
and intact edge integration of the defect with the
surrounding native cartilage. Upon closer observation
at the defect region, Group A aggregates (R01 and
R04) showed columnar arrangement and are surrounded by tiny lacunae spaces. The lacunae spaces
increased in size at the osteochondral junction. R03
JOURNAL OF ORTHOPAEDIC RESEARCH AUGUST 2017
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Figure 3. Histology (H&E, Saf-O) and immunohistochemistry (collagen I, II, and, aggrecan antibody staining) for Group A. Black
arrowheads indicate defect region. Numbers on the top refer to the rat number (see Supplemental Fig. S2). Note that the aggrecan and
collagen II staining were most intense for the R04 left knee. Scale bar ¼ 200 mm. Below the histology image is a stacked column plot
showing the histological score distribution for cartilage thickness Safranin O staining reconstruction of subchondral bone, and edge
integration for the newly regenerated tissue at the defect area for 8-week implants (Group A).

and R04 showed intense collagen II and aggrecan
pericellular staining. Apart from R02, there was no
presence of cellular clusters in any of the Group A
defects. There were small aggregates at the defect site,
but it was not possible to say whether they were the
implanted rBMSC aggregates or host-cell aggregates.
Figure 5 displays representative sections stained
with H&E, Saf-O for GAGs, collagen I, II, and
aggrecan immunostaining for Group B. R06 and R08
sections did not display any Saf-O staining, but
intense staining for R07 and staining around the
defect area for R05. Sixty percent of the samples had a
Saf-O score of 1 (slight staining) and the remaining
40% a score of 3 (nearly normal staining) (Fig. 4a). As
indicated by Figure 4, 80% of the knees exhibited 75–
100% cartilage thickness and reduced subchondral
bone reduction. Sixty percent of the knees had
smooth and intact edge integration of the regenerated
JOURNAL OF ORTHOPAEDIC RESEARCH AUGUST 2017

cartilage with the surrounding tissue. There were no
distinct lacunae observed except for R05 and R08,
where the lacunae spaces increased at the osteochondral junction. R06 showed intense collagen II and
aggrecan pericellular staining. For R06, the cells in
the defect region had more intense pericellular collagen I and II staining compared to the surrounding
tissue. H&E and Saf-O staining of R07 revealed
aggregates at the osteochondral interface.
Figure 6 shows representative sections stained with
H&E, Saf-O for GAGs, collagen I, II, and aggrecan
immunostaining for the fibrin-only group. Saf-O staining was prevalent in the defect area for R07 and R09.
The staining of Saf-O in the native tissue was evident
for R02 and R05. Eighty percent of the fibrin group
showed moderate staining of Saf-O (Fig. 6). Collagen I
staining was intense in the defect area for R05 and
stained deeper in the bone defect region for R02 and
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Figure 4. Stacked column plot showing the
histological score distribution for (a) cartilage
thickness, (b) Safranin O staining, (c) reconstruction of subchondral bone, and (d) edge integration
for the newly regenerated tissue at the defect area
for 8-week implants. The sections were scored
using modified O’Driscoll score as shown in Table
S 2. All groups had a sample size of n ¼ 5.

R03. One hundred percent cartilage thickness was
observed in 60% of the knees. Just like the sham
defect group, 80% of the samples had reduced subchondral bone regeneration and only 60% showed
superficial horizontal lamination. The regenerated
tissue of the fibrin group did not show any columnar
organization of cells. The cells in the regenerated
tissue for R07 showed intense collagen I staining
compared to the surrounding cartilage tissue and,
similarly, the defect area tissue had increased aggrecan around the cells compared to the surrounding
tissue. In general, there was no appearance of cell
clusters in any of the images.
Figure 7 displays representative sections stained
with H&E, Saf-O for GAGs, collagen I, II, and
aggrecan immunostaining for the sham knee surgeries. R01 demonstrated distributed Saf-O staining, but
the regenerated tissue looked weak with a visible
fissure in the bone-cartilage interface. R08 and R10
showed minimal to no Saf-O staining at the defect
region. R04 and R06 on the other hand had Saf-O
staining at the regenerated cartilage surface. As
indicated by the morphometric analysis, 80% of the
group had moderate Saf-O staining and the remaining
20% had regular Saf-O staining, comparable to that of
native cartilage (Fig. 4). Collagen II staining was
evident for the regenerated surface for R01, R08, and
R10, and aggrecan immunostaining was intense for
R08 and R10. Collagen I was not evident for any other
group except R08. Forty percent of the samples
showed 100% of normal cartilage thickness and the
remaining 60% had 50–75% of native tissue thickness
(Fig. 4). Eighty percent of the samples had reduced
subchondral bone regeneration and the remaining 20%

showed normal bone regeneration without any sclerosis or loss of bone tissue. Concerning edge integration
with the native tissue, 60% showed superficial horizontal lamination and 40% showed smooth and intact
integration. The regenerated tissue of the sham group
did not show any columnar organization. Only R04
showed intense aggrecan staining of cells in the defect
area compared to the surrounding tissue. There were
no cell clusters in any of the images.

DISCUSSION
In the current pilot study, we have introduced a new
method to incorporate cellular aggregates with fibrin
into an animal model as a proof of concept study. The
rat trochlear groove is an established animal model
that provided a great insight into both the potential and
the limitations to the aggregate-based approach.55,56
As noted at 8 weeks, the fibrin-only control group
demonstrated extensive tissue regeneration, marked
by full thickness tissue, presence of GAGs, dense
collagen II, and aggrecan immunostaining. In the
experimental groups, Group B had the highest average
morphological score and the highest percentage filling
of the defect area compared to all other groups. From
the data presented here, there is evidence that dense
rBMSC aggregates (Group B) may be beneficial for
osteochondral tissue engineering. The cells were regular cartilage-like cells and did not exhibit any hypercellularity. Since there was no strong collagen I
staining, it may be indicative of a hyaline-like cartilage. The lack of intense collagen II staining may
additionally indicate the absence of mature hyaline
cartilage but may be indicative of a maturing phase of
the tissue.
JOURNAL OF ORTHOPAEDIC RESEARCH AUGUST 2017
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Figure 5. Histology (H&E, Saf-O) and immunohistochemistry (collagen I, II, and aggrecan antibody staining) for Group B. Black
arrowheads indicate defect region. Numbers on the top refer to the rat number (see Supplemental Fig. S2). Note the more intense stain
for collagen II in R06. Scale bar ¼ 200 mm. Below the histology image is a stacked column plot showing the histological score
distribution for cartilage thickness Safranin O staining reconstruction of subchondral bone, and edge integration for the newly
regenerated tissue at the defect area for 8-week implants (Group B).

A potential limitation with respect to the use of rat
trochlear grooves for a cartilage regeneration study is
that the negative control group may not be ideal. A
primary observation was the spontaneous healing of
all of the sham groups. Previous studies by other
groups that had looked at sham surgery in the rodent
trochlear groove region (rat and rabbit) had also
observed that this may be a common trend for a
typical small animal model.52,53 Additionally, in the
current study the starting weights of the rats were
comparable; however, variation in the ages of the rats
might have contributed toward a slightly different
result owing to different regeneration rates of both the
sham and experimental groups.
The defect size was deemed critical and selected
based on previous studies that are cited in the manuscript. As a next step, to distinguish between spontaneous and focused regeneration, load-bearing regions of
the knee such as the medial and femoral condyle will be
JOURNAL OF ORTHOPAEDIC RESEARCH AUGUST 2017

explored in rodents and other animal models. The
trochlear groove in a lower weight-bearing region is
considered an appropriate model for proof of concept
studies.57,58 Earlier studies that employed biomaterials
on rat trochlear groove regeneration for critical sized
defects have shown similar rates of regeneration.59,60
Although previous rat studies have not explicitly
provided aggrecan immunohistochemistry, based on
morphological scoring and basic histology (H&E, SafO), similar rates of regeneration may be inferred.42,61
Munirah et al.62 have demonstrated that fibrin mixed
with autologous cells resulted in osteochondral regeneration in a sheep model. Similarly, Deponti et al.63
demonstrated that fibrin mixed with porcine cells
possessed enhanced in vivo properties, compared to in
vitro conditions, for increased cell viability and activity.
Overall, the current study adequately established
proof of concept. The cellular aggregates did not
necessarily demonstrate conclusive outperformance of
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Figure 6. Histology (H&E, Saf-O) and immunohistochemistry (collagen I, II, and, aggrecan antibody staining) for the fibrin-only
Group. Black arrowheads indicate defect region. Numbers on the top refer to the rat number (see Supplemental Fig. S2). Note that the
R05 section showed almost zero staining for Saf-O and the bone region for R09 was deeply stained for Saf-O, suggesting neo-cartilage
formation. Scale bar ¼ 200 mm. Below the histology image is a stacked column plot showing the histological score distribution for
cartilage thickness Safranin O staining reconstruction of subchondral bone, and edge integration for the newly regenerated tissue at
the defect area for 8-week implants (Group C).

the fibrin group. The results of the current study, with
differences between Groups A and B, suggested that
there may be more effective ways to combine fibrin
with cell aggregates. For example, exploring different
cell densities for the aggregates, larger numbers of
aggregates, aggregates of other cell types (e.g., Wharton’s jelly cells61–63), pre-treatment of aggregates, or
differences in surgical placement procedure may be
warranted for future investigation in an attempt to
more conclusively prove the hypothesis that aggregates provide better quality and a more consistent
cartilage regeneration compared to the controls.
Now that the feasibility and the potential of the
aggregate technology has been demonstrated, experimental designs will be expanded in future studies to
include higher load-bearing regions, larger defect

sizes, bigger animal models, larger aggregate sizes,
higher aggregate numbers and cell density of the
aggregates, and more sophisticated techniques to
differentiate between the implanted and host cells
even after several months of implantation. From a
clinical standpoint, comparison of cell suspensions
with fibrin versus cell aggregates with fibrin would
yield a meaningful and more direct implication of the
efficacy of aggregate technology over conventional cell
suspension techniques. Furthermore, aggregate technology may augment current existing methods such as
autologous chondrocyte implantation (ACI) to produce
a new class of products for treating focal cartilage
lesions. While ACI employs autologous cells that
require a long culture time and limited cell viability
from older patients, allogeneic cells can be readily
JOURNAL OF ORTHOPAEDIC RESEARCH AUGUST 2017
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Figure 7. Histology (H&E, Saf-O) and immunohistochemistry (collagen I, II, and, aggrecan antibody staining) for the sham Group.
Black arrowheads indicate defect region. Numbers on the top refer to the rat number (see Supplemental Fig. S2). Note that R01 has a
deep crevice on the cartilage surface. Scale bar ¼ 200 mm. Below the histology image is a stacked column plot showing the histological
score distribution for cartilage thickness Safranin O staining reconstruction of subchondral bone, and edge integration for the newly
regenerated tissue at the defect area for 8-week implants (Group D).

available in an off-the-shelf format. The current study
looked at allogeneic aggregates, and, although longterm implications were not evaluated, the model
provides a method for reducing time constraints and
provides a better model compared to ACI, thus preventing multiple surgeries and reducing the overall
healthcare costs.
The current study has clearly established a proof of
concept for a novel approach of incorporating aggregates of rBMSCs with two different cell densities for
osteochondral defect repair.

CONCLUSIONS
The current study demonstrated a cell-based approach
where stem cell aggregates employed with fibrin were
used for regenerating the osteochondral interface
tissue in a rat knee defect model. This is the first in
vivo study that employed dense stem cell aggregates
with fibrin in a rat trochlear knee defect model. Stem
JOURNAL OF ORTHOPAEDIC RESEARCH AUGUST 2017

cells presented in a 3D aggregate form along with
fibrin seemed to enhance regeneration.
In conclusion, the inclusion of fibrin showed some
degree of regeneration that may have been enhanced
with the higher aggregate density group. Between the
two experimental groups, the higher cell density aggregate group (Group B) demonstrated superior cartilage
regeneration compared to all other groups and arguably
had the most complete defect filling. The complete filling
was believed to be the result of denser cellular aggregates
in Group B that enabled better cell-to-cell interaction,
filled the defect and remained intact due to its relative
density. The merit of the study design shows potential in
that the cellular density of the aggregates is an important
parameter in osteochondral tissue regeneration, which
may further be facilitated by the priming of rBMSC
aggregates and exploration of even higher cell densities
or larger numbers of aggregates, which is certainly
worthy of long-term systematic evaluation in the future.

IN VIVO EVALUATION OF STEM CELL AGGREGATES
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